Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjent ma co najmniej 18 lat
- •Pacjent wyraził świadomą zgodę na uczestnictwo
- •Pacjent ma wskazania medyczne do użycia implantu Ennovate Cervical
- •Pacjentka nie jest w ciąży
✗ Disqualifies
- •Pacjent nie chce lub nie może uczestniczyć w badaniu kontrolnym
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 3, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (4)
Schön Klinik Hamburg Eilbek
Hamburg, Germany
Krankenhaus Ludmillenstift Meppen
Meppen, Germany
Städtisches Klinikum Dresden
Dresden, Germany
Berufsgenossenschaft Klinikum Bergmannstrost Halle / Saale
Halle, Germany
Trial contact
Sarah Mattes
Stefan Maenz, Dr.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/4/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.